ERBB2 and breast carcinoma: The HER2 receptor tyrosine kinase is also present at low levels in healthy epithelial tissues, with HER2 gene amplification occurring in around 15–30% of breast cancers, and other mechanisms of HER2 overexpression described for other cancer entities.26